Suchergebnisse - "Elmeliegy, Mohamed"

PubPharm (5)

1

Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer : TALAPRO-2 phase III study design

enthalten in: Future oncology (London, England) | 2022

von Agarwal, N. | Azad, A. | Shore, N. | +10

2

Exposure-Safety Analyses of Talazoparib in Patients With Advanced Breast Cancer and Germline BRCA1/2 Mutations in the EMBRACA and ABRAZO Trials

enthalten in: Journal of clinical pharmacology | 2020

von Elmeliegy, M. | Yu, Y. | Litton, J. | +5

3

Talazoparib Exposure-Efficacy Analysis in Patients With Advanced Breast Cancer and Germline BRCA1/2 Mutations in the EMBRACA Trial

enthalten in: Journal of clinical pharmacology | 2020

von Yu, Y. | Elmeliegy, M. | Litton, J. | +4

4

Evaluation of the effect of P-glycoprotein inhibition and induction on talazoparib disposition in patients with advanced solid tumours

enthalten in: British journal of clinical pharmacology | 2020

von Elmeliegy, M. | Láng, I. | Smolyarchuk, E. | +4

5

Talazoparib in Patients with a Germline BRCA-Mutated Advanced Breast Cancer : Detailed Safety Analyses from the Phase III EMBRACA Trial

enthalten in: The oncologist | 2020

von Hurvitz, S. | Gonçalves, A. | Rugo, H. | +14

1
[1]